Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis.

ABSTRACT: Elucidation of distinct T-cell subsets involved in multiple sclerosis immune-pathophysiology continues to be of considerable interest since an ultimate goal is to more selectively target the aberrant immune response operating in individual patients. While abnormalities of both effector (Teff) and regulatory (Treg) T cells have been reported in patients with multiple sclerosis, prior studies have mostly assessed average abnormalities in either limb of the immune response, rather than both at the same time, which limits the ability to evaluate the balance between effectors and regulators operating in the same patient. Assessing both phenotypic and functional responses of Teffs and Tregs has also proven important. In studies of adults with multiple sclerosis, in whom biological disease onset

SUBMITTER: Mexhitaj I 

PROVIDER: S-EPMC6391601 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature